{"id":198009,"date":"2024-10-19T12:36:24","date_gmt":"2024-10-19T12:36:24","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-tir24971-2013-ra-2016\/"},"modified":"2024-10-25T05:09:39","modified_gmt":"2024-10-25T05:09:39","slug":"aami-tir24971-2013-ra-2016","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-tir24971-2013-ra-2016\/","title":{"rendered":"AAMI TIR24971 2013 RA 2016"},"content":{"rendered":"
Provides guidance that addresses specific areas that are problematic for those implementing a risk management system.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | AAMI\/ISO TIR24971:2013, Medical devices \u2014 Guidance on the application of ISO 14971 <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | AAMI Technical Information Report ANSI Technical Report <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Background of ANSI\/AAMI adoption of ISO\/TS 24971:2013 <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 1 Scope 2 The role of international product safety and process standards in risk management 2.1 Overview <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 2.2 Use of international product safety standards in risk management <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 2.3 International process standards and ISO 14971 <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 3 Developing the policy for determining the criteria for risk acceptability <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 4 Production and post-production feedback loop 4.1 Overview 4.2 Observation and transmission <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 4.3 Assessment 4.4 Action <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 5 Differentiation of information for safety and disclosure of residual risk 5.1 Difference between \u201cinformation for safety\u201d and \u201cdisclosure of residual risk\u201d 5.2 Information for safety <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 5.3 Disclosure of residual risk 6 Evaluation of overall residual risk 6.1 Overview <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 6.2 Inputs and other considerations for overall residual risk evaluation <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" AAMI\/ISO TIR24971:2013\/(R)2016 – Medical devices-Guidance on the application of ISO 14971<\/b><\/p>\n |